Provided by Tiger Trade Technology Pte. Ltd.

Xeris Pharmaceuticals Inc

7.94
+0.22502.92%
Volume:388.05K
Turnover:3.05M
Market Cap:1.45B
PE:-77.79
High:7.99
Open:7.80
Low:7.78
Close:7.71
52wk High:10.08
52wk Low:5.25
Shares:182.32M
Float Shares:172.57M
Volume Ratio:2.02
T/O Rate:0.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1020
EPS(LYR):0.0032
ROE:-617.16%
ROA:6.13%
PB:-148.62
PE(LYR):2,474.28

Loading ...

Xeris Biopharma to Report Q2 Results, Host Conference Call

Reuters
·
Jul 23

Xeris Biopharma CFO Steven Pieper Disposes of 45,000 Common Shares Worth $385,876.20

Reuters
·
Jul 08

Xeris Names John Shannon as Chair of the Board

Reuters
·
Jul 06

Why Xeris Biopharma (XERS) Is Up 7.7% After Governance, IP, And Balance Sheet Moves - And What's Next

Simply Wall St.
·
Jul 05

Xeris Biopharma Director Nerissa Kreher Files Initial Beneficial Ownership Statement

Reuters
·
Jul 03

Xeris Biopharma Chief Legal Officer Beth Hecht Sells 16,666 Shares Worth $133,865.06

Reuters
·
Jul 03

Xeris Biopharma Grants 221,323 Inducement Rsus to 47 New Employees

Reuters
·
Jul 03

Xeris Taps CEO to Additionally Serve as Chairman

Dow Jones
·
Jun 30

Palvella Therapeutics Appoints Savara CEO Matt Pauls to Board of Directors

Reuters
·
Jun 30

Xeris Names CEO John Shannon Board Chair, Effective July 1, 2026

Reuters
·
Jun 30

Xeris Announces Updates to Its Board of Directors

THOMSON REUTERS
·
Jun 30

Xeris Biopharma Holdings - Marla Persky to Transition to Lead Independent Director

THOMSON REUTERS
·
Jun 30

Xeris Biopharma Holdings - Appoints John Shannon as Chair of the Board

THOMSON REUTERS
·
Jun 30

Xeris Biopharma Gets Notice of Allowance From US Patent and Trademark Office for New KEVEYIS Patent

MT Newswires Live
·
Jun 12

Xeris Biopharma gets USPTO notice of allowance for Keveyis patent extending protection to 2039

Reuters
·
Jun 12

Analysts Are Bullish on Top Healthcare Stocks: Omnicell (OMCL), Xeris Pharmaceuticals (XERS)

TIPRANKS
·
Jun 11

Xeris Biopharma announces private exchange of convertible notes

TIPRANKS
·
Jun 11

BRIEF-Xeris Biopharma Announces Private Exchange Of Convertible Notes

Reuters
·
Jun 11

Xeris Biopharma retires USD 23 million of 8% convertible notes in cash-and-stock exchange

Reuters
·
Jun 11

Xeris Biopharma Announces Private Exchange of Convertible Notes

THOMSON REUTERS
·
Jun 11